Collectively, this positions the loss of hepatic CEACAM1 expression (and its resulting hyperinsulinemia and insulin resistance) on the crossroad of the pathogenesis of NAFLD and obesity. The gene discussed is CEACAM1; the disease is hyperinsulinism.